C17 H17 N5 O2
A1MCD
4-oxidanyl-~{N}-(2-phenylpropan-2-yl)-2-pyrazol-1-yl-pyrimidine-5-carboxamide
Description
Physiochemical properties
Bound structures
Interaction statistics
Ligand-specific databases
We have redesigned this page to enhance your experience. Take an on-page tour.
Synonyms
4-oxidanyl-~{N}-(2-phenylpropan-2-yl)-2-pyrazol-1-yl-pyrimid...Show more
Formula
Standard InChI
InChI=1S/C17H17N5O2/c1-17(2,12-7-4-3-5-8-12)21-15(24)13-11-18-16(20-14(13)23)22-10-6-9-19-22/h3-11H,1-2H3,(H,21,24)(H,18...Show more
Standard InChI Key
OWIYRQCICNVJRW-UHFFFAOYSA-N
SMILES
CC(C)(c1ccccc1)NC(=O)c2cnc(nc2O)n3cccn3
Source OpenEye
First observed in
Overall view, and highlighted
scaffolds and fragments ![help icon]()
This image gallery displays several views of the ligand structure:
- Basic Structural Representation: Shows the overall structure of the ligand.
- Detailed Structural Representation: Highlights individual atoms within the ligand.
- Murcko Scaffold: Presents the scaffold of the ligand highlighted in yellow.
- Highlighted Fragments: Displays various ligand fragments, highlighted in yellow.
This image gallery displays several views of the ligand structure:
- Basic Structural Representation: Shows the overall structure of the ligand.
- Detailed Structural Representation: Highlights individual atoms within the ligand.
- Murcko Scaffold: Presents the scaffold of the ligand highlighted in yellow.
- Highlighted Fragments: Displays various ligand fragments, highlighted in yellow.
Displayed: 1 / 2